Tag:
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- HTA in Medtech - Free SymposiumSaturday, June 2, 2012 — ISPOR Washington
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
Press Releases
- PPD Names David Simmons Chairman and CEO
- Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
- PPD Names David Simmons Chairman and CEO
- NICE recommends new treatment option for people with common heart condition
- Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement
- More Press Releases
Featured Jobs
-
Sr. IT Infrastructure Architect Job
Celgene Corporation - Berkeley Heights, NJ, US -
Director, Shared Services Americas Lead Job
Celgene Corporation - Berkeley Heights, NJ, US -
Entry Level Process Engineer and Lead Process Engineer
Foster Wheeler Biokinetics - San Francisco, CA -
Sr. Director/Executive Director of Operations, Inflammation and Immunology CRD Job
Celgene Corporation - Tokyo, Ja, US -
Sr. Director, Healthcare Compliance Audit Job
Celgene Corporation - Summit, NJ, US
